Isofistularin-3, a direct DNA-competitive DNMT1 inhibitor with an IC50 of 13.5 µM, functions as a DNA demethylating agent, leading to cell cycle arrest and increased sensitivity to TRAIL in cancer cells. Additionally, it can be employed as an ADC cytotoxin.
